Image
30.08.2022
Our new Prime Minister must take diabetes seriously
Why it is vital that our government commits to improving diabetes care, and how you can help us influence...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more